Published in J Neurol Neurosurg Psychiatry on December 01, 2004
Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology (2004) 2.57
Zonisamide for weight loss in obese adults: a randomized controlled trial. JAMA (2003) 2.17
Dynamic perception of facial affect and identity in the human brain. Cereb Cortex (2003) 2.00
Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology (2004) 1.88
Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. Neurology (2004) 1.74
Facial recognition deficits and cognition in schizophrenia. Schizophr Res (2004) 1.52
Psychiatric adverse events during levetiracetam therapy. Neurology (2003) 1.38
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav (2003) 1.15
Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res (2003) 1.11
Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia (2003) 1.09
The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav (2003) 1.07
Recognition of emotion from moving facial and prosodic stimuli in depressed patients. J Neurol Neurosurg Psychiatry (2004) 1.03
Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res (2003) 1.00
Valproate potentiates androgen biosynthesis in human ovarian theca cells. Endocrinology (2003) 0.98
The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia (2003) 0.95
Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry (2003) 0.95
Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav (2004) 0.94
Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia (2001) 0.94
Antiepileptic drugs and reduced bone mineral density. Epilepsy Behav (2004) 0.94
Anticonvulsant-induced bone disease: a plea for monitoring and treatment. Arch Neurol (2001) 0.91
Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord (2003) 0.87
The importance of being seizure free: topiramate and psychopathology in epilepsy. Epilepsy Behav (2003) 0.85
The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. J Clin Psychopharmacol (2004) 0.84
Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures. J Clin Psychiatry (2003) 0.83
Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. Seizure (2004) 0.82
Psychiatric uses of antiepileptic treatments. Epilepsy Behav (2002) 0.81
Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. Neurology (2004) 0.81
Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women? Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.79
Development of melancholia during carbamazepine treatment in borderline personality disorder. J Clin Psychopharmacol (1986) 0.78
Psychopharmacology: atypical antipsychotic dosing: the effect of co-medication with anticonvulsants. Psychiatr Serv (2004) 0.78
Osteopenia associated with divalproex sodium. J Clin Psychopharmacol (2004) 0.77
Valproate-induced parkinsonism in a demented elderly patient. J Clin Psychiatry (2002) 0.77
Extrapyramidal syndrome due to valproate administration as an adjunct to lithium in an elderly manic patient. Int J Geriatr Psychiatry (1997) 0.77
What Valproate Does and Doesn't Do. Epilepsy Curr (2004) 0.77
Selective disturbance of movement vision after bilateral brain damage. Brain (1983) 2.08
Visual field recovery from scotoma in patients with postgeniculate damage. A review of 55 cases. Brain (1985) 1.54
The contribution of the 'second' visual system to directed visual attention in man. Brain (1979) 1.16
Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis. Psychol Med (2008) 1.08
Restitution of visual function in patients with cerebral blindness. J Neurol Neurosurg Psychiatry (1979) 1.06
Neuropsychological assessments before and after treatment in patients with anorexia nervosa and bulimia nervosa. J Psychiatr Res (1999) 0.99
Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychol Med (2004) 0.98
The brain activity related to residual motion vision in a patient with bilateral lesions of V5. Brain (1994) 0.97
Visual motion perception after brain damage: II. Deficits in form-from-motion perception. Neuropsychologia (1997) 0.96
"Blindsight": improvement of visually guided eye movements by systematic practice in patients with cerebral blindness. Neuropsychologia (1980) 0.96
Motion and shape perception in cerebral akinetopsia. Brain (1995) 0.92
Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology (2008) 0.92
Registration of light stimuli in the cortically blind hemifield and its effect on localization. Behav Brain Res (1980) 0.91
Recovery of visual functions in patients with cerebral blindness. Effect of specific practice with saccadic localization. Exp Brain Res (1981) 0.90
Visual motion perception after brain damage: I. Deficits in global motion perception. Neuropsychologia (1997) 0.88
The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism. Psychoneuroendocrinology (2004) 0.88
Residual motion perception in a "motion-blind" patient, assessed with limited-lifetime random dot stimuli. J Neurosci (1991) 0.87
[Anamnesis of brain-originated vision disorders]. Nervenarzt (1990) 0.87
Speechreading in the akinetopsic patient, L.M. Brain (1997) 0.87
Cognitive function in acromegaly: description and brain volumetric correlates. Pituitary (2012) 0.87
Collicular function in human vision. Exp Brain Res (1979) 0.86
[The phenomenon of periodic alternating eye deviation (author's transl)]. Arch Psychiatr Nervenkr (1970) (1977) 0.86
Comparing the visual deficits of a motion blind patient with the visual deficits of monkeys with area MT removed. Neuropsychologia (1997) 0.86
Subcortical control of visual thresholds in humans: evidence for modality specific and retinotopically organized mechanisms of selective attention. Exp Brain Res (1977) 0.85
The "motion-blind" patient: low-level spatial and temporal filters. J Neurosci (1989) 0.83
[Hemianopic dyslexia and its treatment]. Nervenarzt (1984) 0.82
Contributions to the study of "blindsight"--II. The role of specific practice for saccadic localization in patients with postgeniculate visual field defects. Neuropsychologia (1984) 0.81
Restitution of visual field in patients with damage to the geniculostriate visual pathway. Hum Neurobiol (1982) 0.81
Diurnal variation of visual field size in patients with postretinal lesions. Exp Brain Res (1977) 0.80
Colour anomia restricted to the left visual hemifield after splenial disconnexion. J Neurol Neurosurg Psychiatry (1980) 0.80
[Perimetric testing of superior colliculus function in man: a case report (author's transl)]. Nervenarzt (1978) 0.80
[Colour perimetry: method and diagnostic value (author's transl)]. Nervenarzt (1981) 0.80
Can a motion-blind patient reach for moving objects? Eur J Neurosci (2000) 0.79
Contributions to the study of "blindsight"--I. Can stray light account for saccadic localization in patients with postgeniculate field defects? Neuropsychologia (1984) 0.79
[The course and prognosis of scotomas in patients with cerebrovascular disorders (author's transl)]. Nervenarzt (1977) 0.79
Seizure induction and magnetic brain stimulation after stroke. Lancet (1992) 0.79
Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment. Pharmacol Biochem Behav (1991) 0.79
[Rehabilitation of sensory functions in patients with post-chiasmatic visual disorders (author's transl)]. Nervenarzt (1978) 0.79
Selective deficit of visual search in moving displays after extrastriate damage. Nature (1989) 0.78
Visual performance and reading capacity of partially sighted persons in a rehabilitation center. Am J Optom Physiol Opt (1985) 0.78
A neurodynamical model of visual attention: feedback enhancement of spatial resolution in a hierarchical system. J Comput Neurosci (2001) 0.78
Phasic electrodermal responses after visual stimulation in the cortically blind hemifield. Behav Brain Res (1980) 0.78
Visual field rehabilitation in the cortically blind? J Neurol Neurosurg Psychiatry (1986) 0.77
Illumination perception in photophobic patients suffering from panic disorder with agoraphobia. Acta Psychiatr Scand (1997) 0.77
Plasticity and rigidity in the representation of the human visual field. Exp Brain Res (1987) 0.76
The influence of visual field disorders on visual identification tasks. Eur Arch Psychiatry Neurol Sci (1986) 0.76
[Selective analysis of movement direction and velocity in the human visual system (author's transl)]. Psychol Forsch (1973) 0.75
[Neglect: the phenomena of unilateral neglect following brain damage]. Fortschr Neurol Psychiatr (1986) 0.75
[Disorders of visual perception]. Nervenarzt (2012) 0.75
Roving eye movements with bilateral symmetrical lesions of the thalamus. J Neurol (1979) 0.75
Reduced dark-adaptation: an indication of lithium's neuronal action in humans. Am J Psychiatry (1990) 0.75
[The frequency of rapid eye movements and blinks as an activation indicator (author's transl)]. J Neurol (1977) 0.75
Brightness perception in the visual field. Effects of retinal position and adaptation level. Psychol Res (1980) 0.75
Lithium effects on ophthalmological-electrophysiological parameters in young healthy volunteers. Acta Psychiatr Scand (1985) 0.75